These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9378497)
1. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1. Nashar TO; Hirst TR; Williams NA Immunology; 1997 Aug; 91(4):572-8. PubMed ID: 9378497 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells. Nashar TO; Betteridge ZE; Mitchell RN Int Immunol; 2001 Apr; 13(4):541-51. PubMed ID: 11282993 [TBL] [Abstract][Full Text] [Related]
3. Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin. Bone H; Eckholdt S; Williams NA Int Immunol; 2002 Jun; 14(6):647-58. PubMed ID: 12039916 [TBL] [Abstract][Full Text] [Related]
4. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Nashar TO; Webb HM; Eaglestone S; Williams NA; Hirst TR Proc Natl Acad Sci U S A; 1996 Jan; 93(1):226-30. PubMed ID: 8552610 [TBL] [Abstract][Full Text] [Related]
5. Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. Turcanu V; Hirst TR; Williams NA Immunology; 2002 Jul; 106(3):316-25. PubMed ID: 12100719 [TBL] [Abstract][Full Text] [Related]
6. Selective induction of CD8+CD4- thymocyte apoptosis mediated by the B-subunit of Escherichia coli heat-labile enterotoxin. Salmond RJ; Williams R; Hirst TR; Williams NA Immunol Lett; 2003 Jul; 88(1):43-6. PubMed ID: 12853160 [TBL] [Abstract][Full Text] [Related]
7. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells. Luross JA; Heaton T; Hirst TR; Day MJ; Williams NA Arthritis Rheum; 2002 Jun; 46(6):1671-82. PubMed ID: 12115200 [TBL] [Abstract][Full Text] [Related]
8. Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions. Fraser SA; de Haan L; Hearn AR; Bone HK; Salmond RJ; Rivett AJ; Williams NA; Hirst TR Infect Immun; 2003 Mar; 71(3):1527-37. PubMed ID: 12595472 [TBL] [Abstract][Full Text] [Related]
9. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells. Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513 [TBL] [Abstract][Full Text] [Related]
10. Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation. Apostolaki M; Williams NA Infect Immun; 2004 Jul; 72(7):4072-80. PubMed ID: 15213152 [TBL] [Abstract][Full Text] [Related]
11. CD8+ T cell apoptosis induced by Escherichia coli heat-labile enterotoxin B subunit occurs via a novel pathway involving NF-kappaB-dependent caspase activation. Salmond RJ; Pitman RS; Jimi E; Soriani M; Hirst TR; Ghosh S; Rincón M; Williams NA Eur J Immunol; 2002 Jun; 32(6):1737-47. PubMed ID: 12115657 [TBL] [Abstract][Full Text] [Related]
12. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants. Nawar HF; Arce S; Russell MW; Connell TD Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982 [TBL] [Abstract][Full Text] [Related]
13. Escherichia coli enterotoxin B subunit triggers apoptosis of CD8(+) T cells by activating transcription factor c-myc. Soriani M; Williams NA; Hirst TR Infect Immun; 2001 Aug; 69(8):4923-30. PubMed ID: 11447169 [TBL] [Abstract][Full Text] [Related]
14. The B subunit of Escherichia coli heat labile enterotoxin abrogates oral tolerance, promoting predominantly Th2-type immune responses. Plant A; Williams R; Jackson ME; Williams NA Eur J Immunol; 2003 Nov; 33(11):3186-95. PubMed ID: 14579287 [TBL] [Abstract][Full Text] [Related]
15. Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli. Martin M; Sharpe A; Clements JD; Michalek SM J Immunol; 2002 Aug; 169(4):1744-52. PubMed ID: 12165495 [TBL] [Abstract][Full Text] [Related]
16. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins. Zhao W; Zhao Z; Russell MW Mol Oral Microbiol; 2011 Jun; 26(3):200-9. PubMed ID: 21545697 [TBL] [Abstract][Full Text] [Related]
17. Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Williams NA; Stasiuk LM; Nashar TO; Richards CM; Lang AK; Day MJ; Hirst TR Proc Natl Acad Sci U S A; 1997 May; 94(10):5290-5. PubMed ID: 9144230 [TBL] [Abstract][Full Text] [Related]
18. Cholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytes. Negri DR; Pinto D; Vendetti S; Patrizio M; Sanchez M; Riccomi A; Ruggiero P; Del Giudice G; De Magistris MT Infect Immun; 2009 May; 77(5):1924-35. PubMed ID: 19223474 [TBL] [Abstract][Full Text] [Related]
19. The B subunit of Escherichia coli heat-labile toxin alters the development and antigen-presenting capacity of dendritic cells. Ji J; Griffiths KL; Milburn PJ; Hirst TR; O'Neill HC J Cell Mol Med; 2015 Aug; 19(8):2019-31. PubMed ID: 26130503 [TBL] [Abstract][Full Text] [Related]
20. The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established experimental autoimmune uveoretinitis. Raveney BJ; Richards C; Aknin ML; Copland DA; Burton BR; Kerr E; Nicholson LB; Williams NA; Dick AD Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4008-17. PubMed ID: 18469197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]